ClinicalTrials.gg
Sign In

Metrorrhagia clinical trials

The registry lists 153 studies for Metrorrhagia across more than 10 countries. 35 are recruiting or about to start. 91 of them are mainly about Metrorrhagia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Metrorrhagia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
81
Recruiting
20
Status unknown
19
Not yet recruiting
13
Active, not recruiting
7
Terminated
6

Phase

Phase 4
17
Phase 3
14
Phase 2
9
Phase 1
6
Early Phase 1
1

Where

United States
43
Egypt
16
China
9
Turkey
9
Thailand
8
Canada
6

Who runs them

Abbott (7) · Oregon Health and Science University (5) · University of Texas Southwestern Medical Center (3) · Bayer (3) · Indiana University (3) · Scott and White Hospital & Clinic (3) · Benha University (2) · Ain Shams Maternity Hospital (2)

What is being tested here

Drugs under test in Metrorrhagia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid324
Ethinyl Estradiol104
Misoprostol103
Estradiol102
Norelgestromin102
Ketorolac101
Cyclobenzaprine101
Calcium Dobesilate101
Chiro-inositol, (+)-101
Lactalbumin101

Drug classes tested here Estrogens 3 open · Hormonal contraceptives 1 open

Coming up

1phase 3 study under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 20 Metrorrhagia studies recruiting now, 9 (45%) set no upper age limit and 11 (55%) stop at 75 or younger. 2 (10%) take children under 18. 20 (100%) are for women only and 0 (0%) for men only; 6 (30%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
102 (10%)0 (0%)
1816 (80%)0 (0%)
3018 (90%)0 (0%)
4019 (95%)0 (0%)
5013 (65%)0 (0%)
659 (45%)0 (0%)
759 (45%)0 (0%)
859 (45%)0 (0%)

Across all 153 studies, recruiting or not: 60% stop at 75 or younger and 57% at 65; 15% take children; 94% are for women only and 0% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Metrorrhagia studies take

Of 43 interventional studies with no phase under Metrorrhagia, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo6–30 · 43 studies—17 mo6–30 · 41 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 153. Browse all 153 → or search them.